Search - tctmd.com

Displaying 961 - 980 of 998

Sort: Relevancy | Date

News Daily News

Cardiologists Perform Bulk of Carotid Stenting Procedures

L.A. McKeown

August 09, 2011

News Daily News

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

August 01, 2011

News Daily News

Stenting Suitable for Extracranial Vertebral Disease

Caitlin E. Cox

July 27, 2011

News Daily News

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

July 25, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

July 20, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

July 05, 2011

News Industry News

Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents

June 26, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

News Daily News

Renal Dysfunction Takes Toll on Carotid Revascularization Outcomes

June 22, 2011

News Daily News

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

L.A. McKeown

June 17, 2011

News Daily News

Syntax Score Predicts 1-Year Risk in ACS Patients

June 06, 2011

News Daily News

Complete Revascularization Irrelevant for Most Multivessel Disease

Caitlin E. Cox

June 03, 2011

News Daily News

CREST Substudy: Even Biomarker-Only MIs Raise Long-term Mortality

June 01, 2011

News Daily News

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

May 31, 2011

News Conference News

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Caitlin E. Cox

May 20, 2011

News Industry News

Titanium-Nitride-Oxide Bio Active Technology in ACS Patients: Present and Future

May 18, 2011

News Daily News

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

May 16, 2011

Advertisement

Cardiologists Perform Bulk of Carotid Stenting Procedures

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

Stenting Suitable for Extracranial Vertebral Disease

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

Ticagrelor Gains FDA Approval for Use in ACS

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Renal Dysfunction Takes Toll on Carotid Revascularization Outcomes

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

Syntax Score Predicts 1-Year Risk in ACS Patients

Complete Revascularization Irrelevant for Most Multivessel Disease

CREST Substudy: Even Biomarker-Only MIs Raise Long-term Mortality

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Titanium-Nitride-Oxide Bio Active Technology in ACS Patients: Present and Future

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content